Meeder Asset Management Inc Agios Pharmaceuticals, Inc. Transaction History

Meeder Asset Management Inc

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 11, 2022	SELL	$29.58 - $49.78 $55,344 - $93,138	-1,871 Closed	0 $0
Q3 2021 Nov 08, 2021	SELL	$41.92 - $58.18 $133,724 - $185,594	-3,190 Reduced 63.03%	1,871 $86,000
Q2 2021 Aug 09, 2021	BUY	$52.06 - $61.27 $260,195 - $306,227	4,998 Added 7933.33%	5,061 $279,000
Q3 2020 Nov 02, 2020	SELL	$33.87 - $55.93 $3,454 - $5,704	-102 Reduced 61.82%	63 $2,000
Q2 2020 Aug 11, 2020	SELL	$34.45 - $53.48 $344 - $534	-10 Reduced 5.71%	165 $8,000
Q1 2020 May 15, 2020	BUY	$31.52 - $53.81 $819 - $1,399	26 Added 17.45%	175 $6,000
Q4 2019 Feb 13, 2020	BUY	$30.08 - $50.59 $421 - $708	14 Added 10.37%	149 $7,000
Q3 2019 Oct 17, 2019	BUY	$32.4 - $49.58 $2,721 - $4,164	84 Added 164.71%	135 $4,000
Q2 2019 Aug 05, 2019	BUY	$46.17 - $68.1 $2,354 - $3,473	51 New	51 $3,000

232

58.1M

403K

469K

Ticker AGIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 54,818,000
Market Cap $2.34B
Description
Agios Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of medicines in the field of cellular metabolism and adjacent areas of biology. The company offers PYRUKYND (mitapivat) an activator of both wild-type and a variety of mutant pyruvate kinase, PK, enzymes for the treatment of hemolytic anemias; and ...

Get notified when there are updates to the investment portfolio of Meeder Asset Management Inc, based on Form 13F filings with the SEC.

Stay updated on Meeder Asset Management Inc with notifications on news.